Tobacco smoke

Intervention1 paper1 finding

  • Humans1

Associations

1

Metabolic dysfunction-associated steatotic liver disease

upin humans1HR 1.23Low certainty

1 study
  1. Tobacco smoke raises the risk of metabolic dysfunction-associated steatotic liver disease in humans (HR 1.23, 95% CI 1.12-1.36).

    Humansin utero tobacco smoke exposuren = 168,814

    Early-life exposure to tobacco smoke, metabolomic perturbation, and metabolic dysfunction-associated steatotic liver disease incidence risk in later life · Environmental pollution (Barking, Essex : 1987) · 21 Sep 2026

Metabolic dysfunction-associated steatotic liver disease →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01